These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2364642)

  • 1. Some factors influencing the efficiency of a jet nebuliser system.
    Smye SW; Shaw A; Norwood HM; Littlewood JM
    Clin Phys Physiol Meas; 1990 May; 11(2):167-75. PubMed ID: 2364642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mathematical model of some aspects of jet nebuliser performance.
    Smye SW; Jollie MI; Littlewood JM
    Clin Phys Physiol Meas; 1991 Aug; 12(3):289-300. PubMed ID: 1934916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement and prediction of drug solvent losses by evaporation from a jet nebuliser.
    Smye SW; Jollie MI; Cunliffe H; Littlewood JM
    Clin Phys Physiol Meas; 1992 May; 13(2):129-34. PubMed ID: 1499255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a spacer on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation.
    Harvey CJ; O'Doherty MJ; Page CJ; Thomas SH; Nunan TO; Treacher DF
    Thorax; 1995 Jan; 50(1):50-3. PubMed ID: 7886649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antibiotic aerosol generation using commercial jet nebulizers.
    Hurley PK; Smye SW; Cunliffe H
    J Aerosol Med; 1994; 7(3):217-28. PubMed ID: 10150480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two commercial jet nebulisers and three compressors for the nebulisation of antibiotics.
    Hung JC; Hambleton G; Super M
    Arch Dis Child; 1994 Oct; 71(4):335-8. PubMed ID: 7979528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of jet nebulisers for lung aerosol therapy.
    Clay MM; Pavia D; Newman SP; Lennard-Jones T; Clarke SW
    Lancet; 1983 Sep; 2(8350):592-4. PubMed ID: 6136746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nebuliser efficiency for aerosolizing pentamidine.
    Smith D; Erskine D; Steele J; Hills D; Gazzard B
    J Pharm Pharmacol; 1992 Jan; 44(1):7-9. PubMed ID: 1350636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the technological parameters of ultrasonic nebulisation on the nebulisation quality of alpha1 protease inhibitor (alpha1PI).
    Flament MP; Leterme P; Gayot A
    Int J Pharm; 1999 Nov; 189(2):197-204. PubMed ID: 10536248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.
    Newman SP; Woodman G; Clarke SW
    Thorax; 1988 Apr; 43(4):318-22. PubMed ID: 3406919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant nebulisation: safety, efficiency and influence on surface lowering properties and biochemical composition.
    Dijk PH; Heikamp A; Piers DA; Weller E; Bambang Oetomo S
    Intensive Care Med; 1997 Apr; 23(4):456-62. PubMed ID: 9142589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.
    Dennis JH; Stenton SC; Beach JR; Avery AJ; Walters EH; Hendrick DJ
    Thorax; 1990 Oct; 45(10):728-32. PubMed ID: 2247862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of nebulisers and compressors for delivery of carbenicillin aerosol.
    Newman SP; Pellow PG; Clarke SW
    Eur J Respir Dis; 1986 Sep; 69(3):160-8. PubMed ID: 3780896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised crossover trial of salbutamol aerosol delivered by metered dose inhaler, jet nebuliser, and ultrasonic nebuliser in chronic lung disease.
    Fok TF; Lam K; Ng PC; So HK; Cheung KL; Wong W; So KW
    Arch Dis Child Fetal Neonatal Ed; 1998 Sep; 79(2):F100-4. PubMed ID: 9828734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct isotopic assessment of aerosolized pentamidine deposition: influence of nebuliser.
    Diot P; Le Pape A; Becquemin MH; Besnier JM; Boissinot E; Bastides F; Benjemaa M; Choutet P; Lemarie E
    Eur J Med; 1993; 2(8):484-8. PubMed ID: 8258049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooling the NGI - an approach to size a nebulised aerosol more accurately.
    Dennis J; Berg E; Sandell D; Ali A; Lamb P; Tservistas M; Karlsson M; Mitchell J
    Pharmeur Sci Notes; 2008 Feb; 2008(1):27-30. PubMed ID: 18430404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of formulation on jet nebulisation quality of alpha 1 protease inhibitor.
    Flament MP; Leterme P; Burnouf T; Gayot A
    Int J Pharm; 1999 Feb; 178(1):101-9. PubMed ID: 10205630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The choice of a compressor for the aerosolisation of tobramycin (TOBI) with the PARI LC PLUS reusable nebuliser.
    de Boer AH; Hagedoorn P; Frijlink HW
    Int J Pharm; 2003 Dec; 268(1-2):59-69. PubMed ID: 14643977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill.
    O'Doherty M; Thomas S; Page C; Bradbeer C; Nunan T; Bateman N
    Thorax; 1990 Jun; 45(6):460-4. PubMed ID: 2392791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization by isotope method of the performance of the pneumatic nebulizer NL9 Atomizer in the production of colistin, tobramycin and amiloride aerosols].
    Diot P; Le Pape A; Boissinot E; Lemarié E
    Rev Mal Respir; 1994; 11(6):573-8. PubMed ID: 7831507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.